Dr. Braden Manns

Svare Professor in Health Economics


Biography

Braden Manns is the Senior Associate Dean, Health Research, and the Associate Vice President in Health Research and a Kidney Specialist at the University of Calgary in the Faculty of Medicine. He holds a CIHR Foundation award in health system funding and was the co-PI of a CIHR funded patient-oriented research network in chronic disease (www.Cansolveckd.ca ). 

He has experience in health system administration, having recently served as Alberta Health Services (AHS) Associate Chief Medical Officer and lead for the Strategic Clinical networks for six years. He served as Interim AHS Vice President on two occasions - once as the Physician lead for Provincial Clinical Operations, and once as the Administrative and Physician lead for Provincial Clinical Programs (between 2021 and 2023). 

Dr. Manns is the Past-President of the Canadian Society of Nephrology and has experience in pharmaceutical priority setting, having served on provincial and national committees for drug evaluation, including a term as Chair of Canadian Expert Drug Advisory Committee from 2006-2008

Education and Training

Dr. Manns has a medical degree from the University of Toronto, and specialty training in Internal Medicine and Nephrology from the University of Calgary. He also has a Master’s in Health Economics from York University..

Research Interests and Expertise

Dr. Manns current research interests include examining the impact of healthcare system structure, examining the cost effectiveness of strategies and health care policies for managing patients with chronic disease, and assessing the implications of different ways to pay physicians, among other projects. He has expertise in Applied Health Economics.

Contact

bjmanns@ucalgary.ca

Dr. Braden Manns

Key Publications

Campbell DJT, Mitchell C, Hemmelgarn BR, Tonelli M, Faris P, Zhang J, Tsuyuki RT, Fletcher J, Au F, Klarenbach S, Exner DV, Manns BJ. Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial. . 2023 Mar 5. Doi: 10.1161/CIRCULATIONAHA.123.064188. PMID: 36871215.

Campbell DJT, Tonelli M, Hemmelgarn BR, Faris P, Zhang J, Au F, Tsuyuki RT, Mitchell C, Pannu R, Campbell T, Ivers N, Fletcher J, Exner DV, Manns BJ; Self-management Support Using Advertising Principles for Older Low Income Adults at High Cardiovascular Risk: a Randomized Controlled Trial. 2023 Mar 5. doi:10.1161/CIRCULATIONAHA.123.064189. PMID: 36871212

Manns BJ, Garg AX, Sood MM, Ferguson T, Kim SJ, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Dixon SN, Alam A, Allu S, Tangri N. Multifaceted Intervention to Increase the Use of Home Dialysis: A Cluster Randomized Controlled Trial.  Clin J Am Soc Nephrol. 2022 Mar 21:CJN.13191021. doi: 10.2215/CJN.13191021. Online ahead of print.PMID: 35314481.

Ogundeji YK, Quinn A, Lunney M, Chong C, Chew D, Hopkin G, Senior P, Sumner G, Williams J, Manns B. Optimizing Physician Payment Models to Address Health System Priorities: Perspectives from Specialist Physicians.  Healthc Policy. 2021 Aug;17(1):58-72. doi: 10.12927/hcpol.2021.26577. PMID: 34543177  

Ogundeji Y, Clement F, Wellstead D, Farkas B, Manns B. Primary care physicians' perceptions of the role of alternative payment models in recruitment and retention in rural Alberta: a qualitative study. CMAJ Open. 2021 Jul 20;9(3):E788-E794. doi: 10.9778/cmajo.20200202.  

Quinn AE, Manns BJ. Improving the Sustainability of Healthcare in Canada through Physician-Engaged Delivery System Reforms.  Healthc Policy. 2021 Feb;16(3):43-50. doi: 10.12927/hcpol.2021.26434. 

Quinn AE, Trachtenberg AJ, McBrien KA, Ogundeji Y, Souri S, Manns L, Rennert- May E, Ronksley P, Au F, Arora N, Hemmelgarn B, Tonelli M, Manns BJ.Impact of payment model on the behaviour of specialist physicians: A systematic review. Health Policy. 2020 Apr;124(4):345-358. doi: 10.1016/j.healthpol.2020.02.007. Epub 2020 Feb 22. PMID: 32115252.

Manns BJ, Wasylak T. Clinical networks: enablers of health system change. CMAJ. 2019 Nov 25;191(47):E1299-E1305. doi: 10.1503/cmaj.190313. No abstract available. PMID:31767705

Quinn AE, Hemmelgarn BR, Tonelli M, McBrien KA, Edwards A, Senior P, Faris P, Au F, Ma Z, Weaver RG, Manns BJ. Association of Specialist Physician Payment Model With Visit Frequency, Quality, and Costs of Care for People With Chronic Disease. JAMA Netw Open. 2019 Nov 1;2(11):e1914861. doi:  0.1001/jamanetworkopen.2019.14861.  PMID: 31702800

Trachtenberg AJ, Manns B. Cost analysis of medical assistance in dying in Canada.CMAJ. 2017 Jan 23;189(3):E101-E105. doi: 10.1503/cmaj.160650.

Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada JAMA. 2009 Oct 7;302(13):1437-43.

Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas, N, Quinn R, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, and Manns BJ.  The Impact of Frequent Nocturnal Hemodialysis and Conventional Hemodialysis on Left Ventricular Mass and Quality of Life.  JAMA, 2007; 298(11): 1291-99